Id |
Subject |
Object |
Predicate |
Lexical cue |
T29201 |
24-35 |
CHEBI:24632;CHEBI:24632 |
denotes |
sed vaccine |
T38172 |
50-59 |
SO:0001117 |
denotes |
s a poten |
T27608 |
92-100 |
SP_9 |
denotes |
develop |
T58136 |
119-128 |
PG_1 |
denotes |
vaccinat |
T77006 |
138-154 |
GO:0000768 |
denotes |
18]. They do not |
T55132 |
166-173 |
BV_9 |
denotes |
vitro c |
T17354 |
192-193 |
PG_18 |
denotes |
|
T34950 |
194-206 |
PG_18;BV_11;CHEBI:17089;CHEBI:17089 |
denotes |
iologically |
T45518 |
210-220 |
SP_7 |
denotes |
, and thei |
T55501 |
255-266 |
CHEBI:60816;CHEBI:60816 |
denotes |
te the immu |
T933 |
262-268 |
UBERON:0002405;GO:0006955 |
denotes |
immune |
T934 |
269-278 |
GO:0006955 |
denotes |
responses |
T935 |
305-316 |
CHEBI:24632;CHEBI:24632 |
denotes |
hydrocarbon |
T26814 |
309-320 |
NCBITaxon:11118 |
denotes |
ocarbon-sta |
T936 |
331-340 |
SO:0001117 |
denotes |
α-helical |
T7832 |
339-349 |
SP_7 |
denotes |
l peptide |
T48409 |
365-371 |
CL:0000084 |
denotes |
inhibi |
T937 |
373-381 |
SP_9 |
denotes |
MERS-CoV |
T39850 |
377-384 |
BV_9 |
denotes |
-CoV in |
T938 |
400-409 |
PG_1 |
denotes |
S protein |
T939 |
419-435 |
GO:0000768 |
denotes |
cell-cell fusion |
T75873 |
424-432 |
SP_7 |
denotes |
cell fus |
T53766 |
443-452 |
GO:0031975 |
denotes |
The epito |
T940 |
447-455 |
BV_9 |
denotes |
epitopes |
T48233 |
464-474 |
SP_7 |
denotes |
from the |
T941 |
474-475 |
PG_18 |
denotes |
S |
T942 |
476-488 |
PG_18;BV_11;CHEBI:17089;CHEBI:17089 |
denotes |
glycoprotein |
T88510 |
481-491 |
CHEBI:60816;CHEBI:60816 |
denotes |
protein of |
T943 |
492-502 |
SP_7 |
denotes |
SARS-COV-2 |
T42500 |
506-517 |
CHEBI:3435;CHEBI:3435 |
denotes |
be used to |
T944 |
537-548 |
CHEBI:60816;CHEBI:60816 |
denotes |
immunogenic |
T33036 |
548-559 |
CHEBI:36357;CHEBI:36357 |
denotes |
multi-epit |
T93888 |
585-594 |
CHEBI:60809;CHEBI:60809 |
denotes |
st novel |
T945 |
594-605 |
NCBITaxon:11118 |
denotes |
coronavirus |
T946 |
624-634 |
SP_7 |
denotes |
SARS-CoV-2 |
T37264 |
647-652 |
UBERON:0002405 |
denotes |
he T |
T947 |
650-656 |
CL:0000084 |
denotes |
T cell |
T948 |
663-671 |
BV_9 |
denotes |
epitopes |
T61933 |
678-691 |
CHEBI:24396;CHEBI:24396 |
denotes |
peptide vacci |
T949 |
711-719 |
SP_7 |
denotes |
COVID-19 |
T950 |
730-738 |
GO:0031975 |
denotes |
envelope |
T72359 |
732-747 |
CHEBI:18154;CHEBI:18154 |
denotes |
velope protein |
T951 |
750-760 |
SP_7 |
denotes |
SARS-CoV-2 |
T952 |
767-778 |
CHEBI:60816;CHEBI:60816 |
denotes |
immunogenic |
T953 |
793-804 |
CHEBI:3435;CHEBI:3435 |
denotes |
Carrageenan |
T61413 |
794-808 |
CHEBI:18154;CHEBI:18154 |
denotes |
arrageenan and |
T86563 |
809-818 |
CHEBI:60809;CHEBI:60809 |
denotes |
its struc |
T954 |
834-843 |
CHEBI:36357;CHEBI:36357 |
denotes |
compounds |
T955 |
868-877 |
CHEBI:60809;CHEBI:60809 |
denotes |
adjuvants |
T50142 |
877-890 |
NCBITaxon:11118 |
denotes |
for enhancin |
T956 |
930-936 |
UBERON:0002405 |
denotes |
immune |
T76167 |
943-958 |
CHEBI:18154;CHEBI:18154 |
denotes |
ement [118]. Th |
T957 |
960-973 |
CHEBI:24396;CHEBI:24396 |
denotes |
glycopeptides |
T26865 |
999-1008 |
CHEBI:75958;CHEBI:75958 |
denotes |
on of sel |
T958 |
1014-1029 |
CHEBI:18154;CHEBI:18154 |
denotes |
polysaccharides |
T959 |
1075-1089 |
CHEBI:18154;CHEBI:18154 |
denotes |
polysaccharide |
T18990 |
1085-1092 |
NCBITaxon:10239 |
denotes |
ride ad |
T960 |
1090-1099 |
CHEBI:60809;CHEBI:60809 |
denotes |
adjuvants |
T961 |
1158-1171 |
NCBITaxon:11118 |
denotes |
coronaviruses |